Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 02, 2015 8:40 AM ET

Pharmaceuticals

Company Overview of Cosmo Pharmaceuticals S.p.A.

Executive Profile

Alessandro E. Della Chà LL.M

Chief Executive Officer and Director, Cosmo Pharmaceuticals S.p.A.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
51€2,662,238
As of Fiscal Year 2014

Background

Mr. Alessandro Della Chà, LLM, has been the Chief Executive Officer of Cosmo Pharmaceuticals S.p.A. since March 27, 2014. Mr. Chà is a Senior Partner at Studio Legale Edoardo Ricci e Associati, Milan. Mr. Chà specializes in company law, mergers and acquisitions. He joined the Studio Legale Edoardo Ricci e Associati in 1988. He served as an assistant of the central director for corporate matters of Fininvest Group from 1987 to 1988. He served as the Non-executive Vice ...

Corporate Headquarters

37C, avenue John F. Kennedy
Luxembourg, -- 1855

Luxembourg

Phone: 352 2784 8749
Fax: --

Board Members Memberships

2006-Present
Chief Executive Officer and Director
2012-2014
Former Director

Education

Master's Degree
University of Leicester
LLB
Universita' degli Studi di Milano

Other Affiliations

Annual Compensation

Salary€465,051
Bonus€1,425,000
Total Annual Compensation€1,890,051

Stocks Options

Unexercisable Options€105,000
Total Number of Options€105,000

Total Compensation

Total Annual Cash Compensation€1,890,051
Total Short Term Compensation€1,890,051
Total Calculated Compensation€2,662,238
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$470.4K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
Jack A. Khattar Founder, Chief Executive Officer, President, Secretary and Director
Supernus Pharmaceuticals, Inc.
$485.7K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cosmo Pharmaceuticals S.p.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.